Reduced Injection Site Pain with Succinate Buffer-Based Adalimumab Biosimilar (ZRC-3197) Injection (SUFFER Study): An Observational Study
Saved in:
Main Authors: | Mihir Gharia, A Sudhakar |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-01-01
|
Series: | Indian Journal of Rheumatology |
Online Access: | http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2019;volume=14;issue=2;spage=151;epage=152;aulast=Gharia |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A case of relapsing polychondritis with laryngeal stenosis successfully controlled with biosimilar adalimumab (ZRC-3197)
by: Manish Dugar, et al.
Published: (2019-01-01) -
Biosimilars in Focus: Evaluating Their Role Compared to Adalimumab in Clinical Practice
by: Dorota Waz, et al.
Published: (2025-01-01) -
Iraqi Registry Data Proves Safety and Efficacy of switching to Adalimumab Biosimilar in Treating Rheumatoid Arthritis
by: Yasameen Abbas, et al.
Published: (2024-12-01) -
Analysis of Therapeutic Options for Noise-Induced Hearing Loss: Retroauricular Injection of Methylprednisolone Sodium Succinate Combined with Hyperbaric Oxygenation
by: Yan Yao, et al.
Published: (2024-09-01) -
Quantification of the cellular content of platelet-rich plasma harvested after injection of filgrastim versus pegfilgrastim biosimilars: a prospective, single-center, crossover study
by: Mohammadreza Abbasian, et al.
Published: (2024-12-01)